Toronto, Canada, June 18, 2019 – WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that it is the first licensed producer (LP) to be included in Shoppers Drug Mart (“Shoppers”) and TruTrace...
Toronto, Canada, June 5, 2019 – WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce the launch of ColorTM Cannabis (“Color”). Color Cannabis products include a variety of strains, in multiple formats, developed...
Net revenues of $3.3 million continues trend of steady increases, up 23% from previous quarter. Management to host a Conference Call on May 31st at 10:00 a.m. Eastern Toronto, Canada, May 31, 2019 – WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer...
Fully-licensed facility to be optimized for extract and concentrate production with capacity of more than 200,000 kgs of biomass by 2020 Toronto, Canada, May 29, 2019 – WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased...
Strategic appointments also include the addition of a Vice-President, Quality Assurance and Global Regulatory Compliance Toronto, Canada, March 5, 2019 – WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce strategic leadership appointments to...
Toronto, Canada, February 25, 2019 – WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that the Saskatchewan Liquor and Gaming Authority (SLGA) has authorized the Company to supply cannabis directly to the province’s...
Throughout Canada, the United States and internationally, therapeutic use of cannabis is increasing among patients supported by a growing consensus of medical professionals. Since doctors are generally trained to practice evidence-based medicine, the amount of research and development going into collecting clinical data and the...
In October 2017, a vote amended Bill C-45 (the Cannabis Act) to include "edibles containing cannabis" and "cannabis concentrates"—but the amendment won't come into effect until 2019, a year after legalization takes place. What are they? Edibles are THC infused candies, baked goods or any food...
